GI side effects affect 10% to 40% of GLP-1 users, particularly during the first few weeks and during each dose escalation
In this study: Adults with overweight or obesity took Wegovy 2.4 mg weekly for 20 weeks
A 70-year-old woman, 52, started semaglutide at 313 pounds
Glutathione in the treatment of chronic fatty liver diseases
Finding the right dosage is crucialtoo little might not be effective, while too much could lead to side effects like nausea
Conclusion GLP-1 alternatives for weight loss, such as Ozempic, Wegovy, Mounjaro, Saxenda, and Rybelsus, offer powerful solutions for managing weight and improving blood sugar control